INS and metabolic dysfunction-associated steatotic liver disease: Subjects with nonobese NAFLD were more likely to be older and middle aged (31-50years) (P < 0.001), higher BMI (P < 0.001), higher ALT (P < 0.001), higher AST (P < 0.001), higher TG (P < 0.001), higher LDL-c (P = 0.031), higher fasting glucose (P < 0.001), higher insulin (P < 0.001), and higher HbA1c (P < 0.001) values relative to patients without NAFLD.